Additionally, the interaction between programmed cell death protein 1 (PD-1) expressed on activated T cells and programmed cell death ligand 1 (PD-L1) expressed on tumor cells may lead to the failure of T-cell therapy (Abate-Daga et al., 2014; Wei et al., 2019). The gene discussed is CD274; the disease is neoplasm.